183 related articles for article (PubMed ID: 2495719)
1. Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.
Bergmann JE; Grabowski GA
Am J Hum Genet; 1989 May; 44(5):741-50. PubMed ID: 2495719
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
[TBL] [Abstract][Full Text] [Related]
3. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Grabowski GA; Dinur T; Osiecki KM; Kruse JR; Legler G; Gatt S
Am J Hum Genet; 1985 May; 37(3):499-510. PubMed ID: 4003396
[TBL] [Abstract][Full Text] [Related]
4. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
[TBL] [Abstract][Full Text] [Related]
5. Properties of beta-glucosidase in cultured skin fibroblasts from controls and patients with Gaucher disease.
Turner BM; Hirschhorn K
Am J Hum Genet; 1978 Jul; 30(4):346-58. PubMed ID: 102189
[TBL] [Abstract][Full Text] [Related]
6. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.
Grabowski GA; Gatt S; Horowitz M
Crit Rev Biochem Mol Biol; 1990; 25(6):385-414. PubMed ID: 2127241
[TBL] [Abstract][Full Text] [Related]
7. In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.
Choy FY; Woo M; Potier M
Biochim Biophys Acta; 1986 Mar; 870(1):76-81. PubMed ID: 3947649
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.
Jonsson LM; Murray GJ; Sorrell SH; Strijland A; Aerts JF; Ginns EI; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1987 Apr; 164(1):171-9. PubMed ID: 3549301
[TBL] [Abstract][Full Text] [Related]
9. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
Håkansson G; Dreborg S; Lindsten J; Svennerholm L
Clin Genet; 1980 Oct; 18(4):268-73. PubMed ID: 6777099
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis and intracellular transport of alpha-glucosidase and cathepsin D in normal and mutant human fibroblasts.
Oude Elferink RP; Van Doorn-Van Wakeren J; Strijland A; Reuser AJ; Tager JM
Eur J Biochem; 1985 Nov; 153(1):55-63. PubMed ID: 3905406
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity in type I Gaucher disease.
Devine EA; Beighton P; Petersen EM; Desnick RJ
Prog Clin Biol Res; 1982; 95():495-510. PubMed ID: 6812084
[TBL] [Abstract][Full Text] [Related]
12. Sulfated N-linked oligosaccharides affect secretion but are not essential for the transport, proteolytic processing, and sorting of lysosomal enzymes in Dictyostelium discoideum.
Cardelli JA; Bush JM; Ebert D; Freeze HH
J Biol Chem; 1990 May; 265(15):8847-53. PubMed ID: 2111325
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting.
Fabbro D; Desnick RJ; Grabowski GA
Am J Hum Genet; 1987 Jan; 40(1):15-31. PubMed ID: 3812484
[TBL] [Abstract][Full Text] [Related]
14. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
Grace ME; Graves PN; Smith FI; Grabowski GA
J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
[TBL] [Abstract][Full Text] [Related]
15. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
Karazeh A; Carroll M
J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
[TBL] [Abstract][Full Text] [Related]
16. The effects of altered N-linked oligosaccharide structures on maturation and targeting of lysosomal enzymes in Dictyostelium discoideum.
Freeze HH; Koza-Taylor P; Saunders A; Cardelli JA
J Biol Chem; 1989 Nov; 264(32):19278-86. PubMed ID: 2509475
[TBL] [Abstract][Full Text] [Related]
17. Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II.
Reuser AJ; Kroos M; Oude Elferink RP; Tager JM
J Biol Chem; 1985 Jul; 260(14):8336-41. PubMed ID: 3159730
[TBL] [Abstract][Full Text] [Related]
18. Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient.
Graves PN; Grabowski GA; Eisner R; Palese P; Smith FI
DNA; 1988 Oct; 7(8):521-8. PubMed ID: 3180993
[TBL] [Abstract][Full Text] [Related]
19. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
[TBL] [Abstract][Full Text] [Related]
20. An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
Kohen E; Kohen C; Hirschberg JG; Santus R; Grabowski G; Mangel W; Gatt S; Prince J
Cell Biochem Funct; 1993 Sep; 11(3):167-77. PubMed ID: 8403230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
